Figure 1:
Figure 1:. EFS (re-treatment or death) of HCL patients after vemurafenib treatment. Patients with CR (solid line) and patients with PR (dashed line) have similar EFS.

EFS (re-treatment or death) of HCL patients after vemurafenib treatment. Patients with CR (solid line) and patients with PR (dashed line) have similar EFS.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal